AI is transforming healthcare and, at the BCRP, we are committed to ensuring that this transformation is driven by scientific excellence, clinical impact and multidisciplinary collaboration. At Medica AI 2026, our team played an active role across both Medica AI –…
‘Made in Madeira’ AI platform supports early cancer detection
The platform will be developed by Vipa.pt, in partnership with the University of Madeira and the Champalimaud Foundation’s Breast Cancer Research Programme, with the aim of supporting the screening for two of the most prevalent forms of cancer in the region….
Improving breast surgery accuracy through patient-specific digital twins
Last month, a multidisciplinary team from the Champalimaud Clinical Centre’s Breast Department performed the first robotic mastectomy in Portugal carried out by a Portuguese surgical team. fchampalimaud.org
Early-stage breast cancer: more effective and less toxic post-operative therapy with low-dose Tamoxifen
The international study coordinated by the Istituto Europeo di Oncologia (IEO) and the Champalimaud Foundation, in Lisbon, is changing the post-surgical standard of care for breast tumours in women with ductal carcinoma in situ and high-risk lesions. The research findings, recently…
Delta Cafés and the Champalimaud Foundation announce an agreement to fund breast cancer research
Last month, a multidisciplinary team from the Champalimaud Clinical Centre’s Breast Department performed the first robotic mastectomy in Portugal carried out by a Portuguese surgical team. fchampalimaud.org




